
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer”, Eur Urol, vol. 60, pp. 1244-50, 2011.
, “Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study”, BMJ Open, vol. 5, p. e008365, 2015.
, “The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation”, Thromb Haemost, 2020.
, “Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide”, JAMA Psychiatry, 2019.
, “Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage”, JAMA Neurol, vol. 74, pp. 173-180, 2017.
, “Beta 2 agonists and the incidence of Parkinson's disease”, Am J Epidemiol, 2020.
, “Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 554-560, 2017.
, “Can the Risk of Severe Depression-Related Outcomes be Reduced by Tailoring the Antidepressant Therapy to Patient Characteristics?”, Am J Epidemiol, 2020.
, “Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study.”, Am J Med, 2019.
, “Comparative effect of statins on the risk of incident Alzheimer disease”, Neurology, vol. 90, pp. e179-e187, 2018.
, “Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study”, BMJ Open, vol. 8, p. e019638, 2018.
, “The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation”, Thromb Haemost, vol. 109, pp. 431-9, 2013.
, “Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study”, Menopause, vol. 21, pp. 1023-6, 2014.
, “Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study”, Neurology, vol. 93, pp. e1010-e1020, 2019.
, “Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 360, p. k872, 2018.
, “Dopamine agonist use and the risk of heart failure”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 34-41, 2012.
, “Hormone replacement therapy and the risk of venous thromboembolism: a population-based study”, J Thromb Haemost, vol. 8, pp. 979-86, 2010.
, “Hormone replacement therapy use and the risk of stroke”, Maturitas, vol. 61, pp. 305-9, 2008.
, “Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study”, J Alzheimers Dis, 2021.
, “Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes”, Eur Heart J, vol. 35, pp. 1881-7, 2014.
, “A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study”, BMC Cardiovasc Disord, vol. 12, p. 49, 2012.
, “Pramipexole use and the risk of pneumonia”, BMC Neurol, vol. 12, p. 113, 2012.
, “Prescribing Trends of Antidepressants and Psychotropic Coprescription for Youths in UK Primary Care, 2000-2018”, J Affect Disord, vol. 287, pp. 19-25, 2021.
, “Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015”, Br J Clin Pharmacol, vol. 82, pp. 858-68, 2016.
, “Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis”, Clin J Am Soc Nephrol, vol. 10, pp. 1716-22, 2015.
, “Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men with Late-Onset Hypogonadism”, Am J Epidemiol, 2019.
, “Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study”, Bmj, vol. 340, p. c2519, 2010.
, “Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017”, Br J Clin Pharmacol, 2021.
, “Trends in the prescription of novel oral anticoagulants in UK primary care”, Br J Clin Pharmacol, vol. 83, pp. 2096-2106, 2017.
, “The use of atypical antipsychotics and the risk of breast cancer”, Breast Cancer Res Treat, vol. 129, pp. 541-8, 2011.
, “Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes”, Epidemiology, vol. 29, pp. 904-912, 2018.
, “Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease”, Br J Clin Pharmacol, vol. 82, pp. 461-72, 2016.
,